Scleroderma Renal Crisis Debute with Thrombotic Microangiopathy: A Successful Case Treated with Eculizumab

Figure 3

Initial increase of creatinine levels showing decrease of renal function and decrease of red blood cells, hemolytic anemia, the breaking point on day 9, after 10 days after trying with RRT and aphaeresis Eculizumab therapy was started with a subsequently recovery of red cell line and creatinine level.